J.R. Andersen

1.7k total citations · 2 hit papers
57 papers, 1.3k citations indexed

About

J.R. Andersen is a scholar working on Rheumatology, Pharmacology and Surgery. According to data from OpenAlex, J.R. Andersen has authored 57 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Rheumatology, 18 papers in Pharmacology and 10 papers in Surgery. Recurrent topics in J.R. Andersen's work include Osteoarthritis Treatment and Mechanisms (34 papers), Inflammatory mediators and NSAID effects (14 papers) and Rheumatoid Arthritis Research and Therapies (10 papers). J.R. Andersen is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (34 papers), Inflammatory mediators and NSAID effects (14 papers) and Rheumatoid Arthritis Research and Therapies (10 papers). J.R. Andersen collaborates with scholars based in Denmark, Germany and United States. J.R. Andersen's co-authors include Asger Reinstrup Bihlet, M.A. Karsdal, I. Byrjalsen, Anne‐Christine Bay‐Jensen, Claus Christiansen, Hans Guehring, C. Ladel, M. Michaelis, F. Eckstein and Virginia B. Kraus and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Gut.

In The Last Decade

J.R. Andersen

54 papers receiving 1.2k citations

Hit Papers

Disease-modifying treatments for osteoarthritis (DMOADs) ... 2016 2026 2019 2022 2016 2019 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Disease-modifying treatments for osteoarthritis (DMOADs) of the knee and hip: lessons learned from failures and opportunities for the future
    2016 274 citations M.A. Karsdal, M. Michaelis et al. Osteoarthritis and Cartilage profile →
  2. Effect of Intra-Articular Sprifermin vs Placebo on Femorotibial Joint Cartilage Thickness in Patients With Osteoarthritis
    2019 242 citations Marc C. Hochberg, Hans Guehring et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.R. Andersen Denmark 16 804 363 332 242 137 57 1.3k
Asger Reinstrup Bihlet Denmark 18 893 1.1× 364 1.0× 341 1.0× 280 1.2× 126 0.9× 81 1.4k
W.E. van Spil Netherlands 20 1.2k 1.5× 421 1.2× 416 1.3× 219 0.9× 148 1.1× 41 1.5k
Augustin Latourte France 15 743 0.9× 232 0.6× 218 0.7× 363 1.5× 82 0.6× 52 1.2k
Colin G. Miller United States 17 469 0.6× 106 0.3× 334 1.0× 198 0.8× 233 1.7× 38 1.1k
Seong Jae Choi South Korea 19 543 0.7× 158 0.4× 91 0.3× 275 1.1× 100 0.7× 33 1.2k
A Lussier Canada 16 456 0.6× 259 0.7× 274 0.8× 264 1.1× 97 0.7× 53 1.2k
Ulrik Mouritzen Denmark 14 201 0.3× 120 0.3× 200 0.6× 154 0.6× 71 0.5× 22 896
Sonia Nasi Switzerland 15 398 0.5× 101 0.3× 86 0.3× 318 1.3× 51 0.4× 33 784
Linda Mindeholm Switzerland 13 279 0.3× 173 0.5× 104 0.3× 359 1.5× 256 1.9× 24 910

Countries citing papers authored by J.R. Andersen

Since Specialization
Citations

This map shows the geographic impact of J.R. Andersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.R. Andersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.R. Andersen more than expected).

Fields of papers citing papers by J.R. Andersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.R. Andersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.R. Andersen. The network helps show where J.R. Andersen may publish in the future.

Co-authorship network of co-authors of J.R. Andersen

This figure shows the co-authorship network connecting the top 25 collaborators of J.R. Andersen. A scholar is included among the top collaborators of J.R. Andersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.R. Andersen. J.R. Andersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bihlet, Asger Reinstrup, et al.. (2024). A phase 2b double-blind placebo-controlled randomized clinical trial of SB-061, an aggrecan mimetic, in patients with symptomatic knee osteoarthritis. Osteoarthritis and Cartilage. 32(11). 1471–1480. 5 indexed citations
2.
Bihlet, Asger Reinstrup, I. Byrjalsen, J.R. Andersen, et al.. (2024). The efficacy and safety of a fixed-dose combination of apocynin and paeonol, APPA, in symptomatic knee OA: A double-blind, randomized, placebo-controlled, clinical trial. Osteoarthritis and Cartilage. 32(7). 952–962. 7 indexed citations
3.
4.
Andersen, J.R., et al.. (2022). Impact of monitoring approaches on data quality in clinical trials. British Journal of Clinical Pharmacology. 89(6). 1756–1766. 3 indexed citations
5.
Andersen, J.R., M.A. Karsdal, Anne‐Christine Bay‐Jensen, et al.. (2021). Does moderate intensity impact exercise and non-impact exercise induce acute changes in collagen biochemical markers related to osteoarthritis? – An exploratory randomized cross-over trial. Osteoarthritis and Cartilage. 29(7). 986–994. 12 indexed citations
6.
7.
Bihlet, Asger Reinstrup, I. Byrjalsen, J.R. Andersen, et al.. (2021). The Efficacy and Safety of Multiple Dose Regimens of Kudzu (Pueraria lobata) Root Extract on Bone and Cartilage Turnover and Menopausal Symptoms. Frontiers in Pharmacology. 12. 760629–760629. 6 indexed citations
8.
Eckstein, F., Marc C. Hochberg, Hans Guehring, et al.. (2020). Long-term efficacy and safety of intra-articular sprifermin in patients with knee osteoarthritis: results from the 5-year forward study. Osteoarthritis and Cartilage. 28. S77–S78. 3 indexed citations
9.
Bihlet, Asger Reinstrup, et al.. (2020). A placebo-controlled, double-blind, randomized, trial of AMZ001 - a novel diclofenac sodium 3.06% gel - for the treatment of knee osteoarthritis symptoms. Osteoarthritis and Cartilage. 28. S484–S484. 1 indexed citations
10.
Bihlet, Asger Reinstrup, et al.. (2020). Clinical and biochemical factors associated with risk of total joint replacement and radiographic progression in osteoarthritis: Data from two phase III clinical trials. Seminars in Arthritis and Rheumatism. 50(6). 1374–1381. 20 indexed citations
11.
12.
Bay‐Jensen, Anne‐Christine, M.A. Karsdal, I. Byrjalsen, et al.. (2019). Biomarkers of bone and cartilage turnover CTX-I and CTX-II predict total joint replacements in osteoarthritis. Osteoarthritis and Cartilage. 27. S31–S32. 6 indexed citations
13.
Bihlet, Asger Reinstrup, I. Byrjalsen, J.R. Andersen, et al.. (2019). Elevated serum biomarkers of inflammatory turnover of collagen types III and VI predict rapid cartilage loss. Osteoarthritis and Cartilage. 27. S104–S105. 3 indexed citations
14.
Bay‐Jensen, Anne‐Christine, Asger Reinstrup Bihlet, I. Byrjalsen, et al.. (2017). Elevated levels of CRPM, an inflammatory biomarker correlating with disease activity in RA, are prognostic of radiographic knee OA. Osteoarthritis and Cartilage. 25. S32–S32. 3 indexed citations
15.
Karsdal, M.A., Erik B. Dam, I. Byrjalsen, et al.. (2015). MRI analysis from two phase 3 randomized clinical trials; treatment of symptomatic knee osteoarthritis with oral salmon calcitonin. Osteoarthritis and Cartilage. 23. A394–A395. 1 indexed citations
16.
Karsdal, M.A., I. Byrjalsen, Peter Alexandersen, et al.. (2015). Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials. Osteoarthritis and Cartilage. 23(4). 532–543. 101 indexed citations
17.
Bihlet, Asger Reinstrup, M.A. Karsdal, Anne‐Christine Bay‐Jensen, et al.. (2015). Clinical Drug Development Using Dynamic Biomarkers to Enable Personalized Health Care in COPD. CHEST Journal. 148(1). 16–23. 19 indexed citations
18.
Alexandersen, Peter, I. Byrjalsen, Anne‐Christine Bay‐Jensen, et al.. (2014). Association between joint space width, Kellgren-Lawrence score, pain and progression in osteoarthritis subjects from two phase III studies – a clinical study reference database. Osteoarthritis and Cartilage. 22. S197–S197.
19.
Floro, Josh, et al.. (2007). P2-157 Impact of maternal psychosocial stress on birth outcomes: a meta-analysis. Early Human Development. 83. S173–S174. 1 indexed citations
20.
Manniche, Claus, A Malchow-Møller, J.R. Andersen, et al.. (1987). Randomised study of the influence of non-steroidal anti-inflammatory drugs on the treatment of peptic ulcer in patients with rheumatic disease.. Gut. 28(2). 226–229. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Asger Reinstrup Bihlet Breakdown of academic impact, for papers by W.E. van Spil Breakdown of academic impact, for papers by Augustin Latourte Breakdown of academic impact, for papers by Colin G. Miller Breakdown of academic impact, for papers by Seong Jae Choi Breakdown of academic impact, for papers by A Lussier Breakdown of academic impact, for papers by Ulrik Mouritzen Breakdown of academic impact, for papers by Sonia Nasi Breakdown of academic impact, for papers by Linda Mindeholm
Rankless by CCL
2026